SI2758394T1 - Heteroaril spojine kot 5-ht4 receptor ligandi - Google Patents
Heteroaril spojine kot 5-ht4 receptor ligandiInfo
- Publication number
- SI2758394T1 SI2758394T1 SI201230163T SI201230163T SI2758394T1 SI 2758394 T1 SI2758394 T1 SI 2758394T1 SI 201230163 T SI201230163 T SI 201230163T SI 201230163 T SI201230163 T SI 201230163T SI 2758394 T1 SI2758394 T1 SI 2758394T1
- Authority
- SI
- Slovenia
- Prior art keywords
- receptor ligands
- heteroaryl compounds
- heteroaryl
- compounds
- ligands
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3203CH2011 | 2011-09-19 | ||
EP12716662.7A EP2758394B1 (en) | 2011-09-19 | 2012-01-05 | Heteroaryl compounds as 5-ht4 receptor ligands |
PCT/IN2012/000011 WO2013042135A1 (en) | 2011-09-19 | 2012-01-05 | Heteroaryl compounds as 5-ht4 receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2758394T1 true SI2758394T1 (sl) | 2015-05-29 |
Family
ID=46001349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201230163T SI2758394T1 (sl) | 2011-09-19 | 2012-01-05 | Heteroaril spojine kot 5-ht4 receptor ligandi |
Country Status (26)
Country | Link |
---|---|
US (2) | US9079894B2 (sl) |
EP (1) | EP2758394B1 (sl) |
JP (1) | JP5714729B2 (sl) |
KR (1) | KR101551481B1 (sl) |
CN (1) | CN103380131B (sl) |
AP (1) | AP3307A (sl) |
AU (1) | AU2012311057B2 (sl) |
BR (1) | BR112014001083B8 (sl) |
CA (1) | CA2823548C (sl) |
CY (1) | CY1116173T1 (sl) |
DK (1) | DK2758394T3 (sl) |
EA (1) | EA022374B1 (sl) |
ES (1) | ES2531885T3 (sl) |
HK (1) | HK1187340A1 (sl) |
HR (1) | HRP20150229T1 (sl) |
IL (1) | IL231305A0 (sl) |
ME (1) | ME02107B (sl) |
MX (1) | MX337721B (sl) |
PL (1) | PL2758394T3 (sl) |
PT (1) | PT2758394E (sl) |
RS (1) | RS53940B1 (sl) |
SG (1) | SG2014003560A (sl) |
SI (1) | SI2758394T1 (sl) |
SM (1) | SMT201500087B (sl) |
WO (1) | WO2013042135A1 (sl) |
ZA (1) | ZA201309100B (sl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103748087A (zh) * | 2011-06-07 | 2014-04-23 | 大日本住友制药株式会社 | 吲唑和吡咯并吡啶衍生物和其药学用途 |
JP2016523813A (ja) * | 2013-04-05 | 2016-08-12 | エービーシー バイオサイエンス エーエス | 医学的使用、特に酸化ストレスまたは炎症に関連する疾患の治療、および臓器の保存または洗浄のための、バレッチンおよびその誘導体 |
NZ720879A (en) | 2013-12-16 | 2017-05-26 | Suven Life Sciences Ltd | Indazole compounds as 5-ht4 receptor agonists |
AP2017009755A0 (en) | 2014-08-16 | 2017-02-28 | Suven Life Sciences Ltd | Process for large scale production of 1-isopropyl-3-{5-[1-(3-methoxypropyl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1h-indazole oxalate |
EP3265459B1 (en) * | 2015-02-13 | 2019-05-15 | Suven Life Sciences Limited | Amide compounds as 5-ht4 receptor agonists |
CN107540568A (zh) * | 2017-08-25 | 2018-01-05 | 许昌恒生制药有限公司 | 一种乙氧酰胺苯甲酯的制备方法 |
MA53918A (fr) * | 2018-10-18 | 2022-01-26 | Suven Life Sciences Ltd | Nouvelles utilisations d'un agoniste du récepteur 5-ht4 |
CN114502540A (zh) | 2019-05-31 | 2022-05-13 | 医肯纳肿瘤学公司 | Tead抑制剂和其用途 |
CN110746450A (zh) * | 2019-09-17 | 2020-02-04 | 济南康和医药科技有限公司 | 一种贝前列素钠关键中间体的合成方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06509574A (ja) * | 1991-08-03 | 1994-10-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5−ht↓4レセプターアンタゴニスト |
TW360653B (en) * | 1995-03-01 | 1999-06-11 | Janssen Pharmaceutica Nv | A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition |
EP0863897B1 (fr) * | 1995-11-09 | 1999-06-16 | Synthelabo | Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one, utiles comme ligands des recepteurs 5-ht4 ou h3 |
GB0115862D0 (en) * | 2001-06-28 | 2001-08-22 | Smithkline Beecham Plc | Compounds |
CA2545092C (en) | 2003-11-24 | 2010-08-17 | Pfizer Inc. | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
EA012615B1 (ru) | 2005-02-22 | 2009-10-30 | Пфайзер Инк. | Производные оксииндола в качестве агонистов 5-htрецептора |
EP1856114B1 (en) | 2005-02-25 | 2014-08-20 | Pfizer Inc. | Benzisoxazole derivatives |
ES2333545T3 (es) | 2005-07-22 | 2010-02-23 | Pfizer, Inc. | Derivados de indazolcarboxamida como agonistas de receptores 5ht4. |
KR101121240B1 (ko) * | 2005-12-23 | 2012-06-12 | 에프. 호프만-라 로슈 아게 | 아릴-아이속사졸-4-일-옥사다이아졸 유도체 |
US20080167286A1 (en) * | 2006-12-12 | 2008-07-10 | Abbott Laboratories | Pharmaceutical compositions and their methods of use |
US20080255203A1 (en) * | 2007-04-12 | 2008-10-16 | Abbott Laboratories | Heterocyclic compounds and their methods of use |
JP5656880B2 (ja) * | 2009-03-09 | 2015-01-21 | グラクソ グループ リミテッドGlaxo Group Limited | Pi3キナーゼの阻害剤としての4−オキサジアゾール−2−イル−インダゾール |
-
2012
- 2012-01-05 DK DK12716662.7T patent/DK2758394T3/en active
- 2012-01-05 RS RS20150234A patent/RS53940B1/en unknown
- 2012-01-05 WO PCT/IN2012/000011 patent/WO2013042135A1/en active Application Filing
- 2012-01-05 AP AP2013007301A patent/AP3307A/xx active
- 2012-01-05 MX MX2013014577A patent/MX337721B/es active IP Right Grant
- 2012-01-05 JP JP2013554062A patent/JP5714729B2/ja active Active
- 2012-01-05 CA CA2823548A patent/CA2823548C/en active Active
- 2012-01-05 SG SG2014003560A patent/SG2014003560A/en unknown
- 2012-01-05 EP EP12716662.7A patent/EP2758394B1/en active Active
- 2012-01-05 ME MEP-2015-47A patent/ME02107B/me unknown
- 2012-01-05 EA EA201391056A patent/EA022374B1/ru unknown
- 2012-01-05 PL PL12716662T patent/PL2758394T3/pl unknown
- 2012-01-05 PT PT127166627T patent/PT2758394E/pt unknown
- 2012-01-05 BR BR112014001083A patent/BR112014001083B8/pt not_active IP Right Cessation
- 2012-01-05 SI SI201230163T patent/SI2758394T1/sl unknown
- 2012-01-05 CN CN201280009072.1A patent/CN103380131B/zh active Active
- 2012-01-05 KR KR1020137020582A patent/KR101551481B1/ko active IP Right Grant
- 2012-01-05 AU AU2012311057A patent/AU2012311057B2/en active Active
- 2012-01-05 ES ES12716662.7T patent/ES2531885T3/es active Active
- 2012-01-05 US US13/982,486 patent/US9079894B2/en active Active
-
2013
- 2013-12-04 ZA ZA2013/09100A patent/ZA201309100B/en unknown
-
2014
- 2014-01-10 HK HK14100305.4A patent/HK1187340A1/zh unknown
- 2014-03-04 IL IL231305A patent/IL231305A0/en active IP Right Grant
-
2015
- 2015-02-26 HR HRP20150229AT patent/HRP20150229T1/hr unknown
- 2015-03-30 CY CY20151100308T patent/CY1116173T1/el unknown
- 2015-04-09 SM SM201500087T patent/SMT201500087B/xx unknown
- 2015-06-10 US US14/735,237 patent/US9636335B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL286152A (en) | Modified imidazopyridinyl-aminopyridine compounds | |
GB201106799D0 (en) | Novel compounds | |
GB201107325D0 (en) | Novel compounds | |
AP3307A (en) | Heteroaryl compounds as 5-HT4 receptor ligands | |
EP2670746A4 (en) | BICYCLIC HETEROARYL COMPOUNDS AS GPR119 RECEPTOR AGONISTS | |
HK1187613A1 (en) | Compounds as histamine h3 receptor ligands h3 | |
EP2717694A4 (en) | NEW COMPOUNDS | |
HK1180955A1 (en) | Heterocyclyl compounds as histamine h3 receptor ligands h3 | |
HUP1100731A2 (en) | Complex forming compounds | |
TH1401001203B (th) | สารประกอบเฮเทอโรเอริลในฐานะที่เป็น 5-ht4 รีเซปเตอร์ลิแกนด์ | |
TH148768B (th) | สารประกอบเฮเทอโรเอริลในฐานะที่เป็น 5-ht4 รีเซปเตอร์ลิแกนด์ | |
GB201111410D0 (en) | Novel compounds | |
GB201111409D0 (en) | Novel compounds | |
GB201111308D0 (en) | Novel compounds | |
GB201111229D0 (en) | Novel compounds | |
GB201109508D0 (en) | Novel compounds | |
GB201109514D0 (en) | Novel compounds | |
GB201106801D0 (en) | Novel compounds | |
GB201104138D0 (en) | Novel compounds | |
GB201103283D0 (en) | Novel compounds | |
GB201103073D0 (en) | Novel compounds | |
GB201101640D0 (en) | Novel compounds | |
GB201101085D0 (en) | Novel compounds |